A phase III randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of PRM-151 in patients with idiopathic pulmonary fibrosis

  • Li, Xun (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date9/08/21 → 8/08/26
View all
View less

Keywords

  • phase 3 study
  • treatment efficacy
  • treatment safety
  • pulmonary fibrosis